Copied to clipboard!
Whole Exome Sequencing
ASTEROID Phase 1 trial of combination IAP inhibitor ASTX660 and pembrolizumab. Matched tumour biopsies and PBMCs were sequenced.
- Type: Exome Sequencing
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000002936 | Illumina NovaSeq X Plus | 32 |
| Publications | Citations |
|---|---|
|
IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial.
Nat Commun 17: 2026 11255 |
0 |
